UNH - UnitedHealth Group Incorporated

UNH

$380.31 2.22 (-0.58%) Last updated: May 31, 2026 04:48

52-Week Range

$380.31

$234.60 $380.31 $404.15

Fundamentals Overview

UnitedHealth Group Incorporated is near the high of its 52-week range with premium valuation, trading relatively flat today.

Valuation premium

P/E 28.7 P/B 3.33 P/S 0.77

Intrinsic value (DCF)

-50.3% downside vs price

Profitability

Net margin 2.7%

Risk (Beta)

0.65 — lower vol

Earnings & growth

EPS $13.24 Rev -1.3% Profit +62700% vs prior qtr

BullzEye Analysis

Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell

Buy

Hold — 57% confidence Risk: Lower Volatility — Beta 0.65. Diversify and only invest what you can afford to lose.

Supporting (Buy):

Analyst grade: B+ · Sentiment improving (2 upgrades) · 3M vs S&P 500: +24.7% · 3M vs Healthcare sector: +39.1%

Pressures (Sell):

DCF 50.3% downside vs price

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap

$345.38B

P/E (TTM)

28.73

EPS (TTM)

$13.24

Dividend Yield

2.32%

52-Week Range

$234.60 - $404.15

Volume vs Avg

N/A

Beta

0.65

About

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for prevent...

Sector: Healthcare

Headquarters: US

Employees: 400,000

IPO Date: Oct 1984

Website: www.unitedhealthgroup.com

Beta: 0.65 (Less volatile than market)

Ratings & Grades at a Glance

Overall rating: B+. Recent institutional grades: majority upgrades. Current institutional positions: Buy: 7, Hold: 1, Outperform: 11, Overweight: 10, Underperform: 1.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $189.01; current price is $380.31. That’s a -50.3% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric	Value
Valuation
P/E (TTM)	28.73
DCF value (model)	$189.01 (-50.3% vs price)
PEG (TTM)	N/A
P/B (TTM)	3.33
P/S (TTM)	0.77
P/FCF (TTM)	17.56
Liquidity & enterprise
Current Ratio (TTM)	0.8
Quick Ratio (TTM)	0.8
Cash Ratio (TTM)	0.25
Profitability
ROE (TTM)	N/A
ROA (TTM)	N/A
Revenue growth (YoY)	N/A
Net margin (TTM)	2.68%
Gross margin (TTM)	18.8%
Operating margin (TTM)	4.19%
Debt to equity (TTM)	N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for UNH.

Analyst Sentiment at a Glance

B+ Sentiment Improving

Buy 7Hold 1Outperform 11Overweight 10Underperform 1

2 upgrades, 0 downgrades

Price Target Consensus

Current $380.31

Median $398.00

Consensus $408.00

Low consensus $345.00

High consensus $492.00

Stock Grades (Institutions)

Institution	Action	Previous Grade	New Grade	Date
Bernstein	maintain	Outperform	Outperform	2026-05-27
Barclays	maintain	Overweight	Overweight	2026-05-26
UBS	maintain	Buy	Buy	2026-05-22
Mizuho	maintain	Outperform	Outperform	2026-05-20
JP Morgan	maintain	Overweight	Overweight	2026-04-28
TD Cowen	maintain	Hold	Hold	2026-04-23
Baird	maintain	Underperform	Underperform	2026-04-22
Morgan Stanley	maintain	Overweight	Overweight	2026-04-22
Leerink Partners	maintain	Outperform	Outperform	2026-04-22
Oppenheimer	maintain	Outperform	Outperform	2026-04-22
Truist Securities	maintain	Buy	Buy	2026-04-22
Argus Research	upgrade	Hold	Buy	2026-04-22
Wells Fargo	maintain	Overweight	Overweight	2026-04-22
RBC Capital	maintain	Outperform	Outperform	2026-04-22
Barclays	maintain	Overweight	Overweight	2026-04-22
Jefferies	maintain	Buy	Buy	2026-04-20
Bernstein	maintain	Outperform	Outperform	2026-04-07
Raymond James	upgrade	Market Perform	Outperform	2026-04-01
Mizuho	maintain	Outperform	Outperform	2026-02-05
JP Morgan	maintain	Overweight	Overweight	2026-02-02
Truist Securities	maintain	Buy	Buy	2026-02-02
Wells Fargo	maintain	Overweight	Overweight	2026-01-30
Barclays	maintain	Overweight	Overweight	2026-01-30
Jefferies	maintain	Buy	Buy	2026-01-28
Leerink Partners	maintain	Outperform	Outperform	2026-01-28
Oppenheimer	maintain	Outperform	Outperform	2026-01-28
UBS	maintain	Buy	Buy	2026-01-28
RBC Capital	maintain	Outperform	Outperform	2026-01-28
Morgan Stanley	maintain	Overweight	Overweight	2026-01-23
Barclays	maintain	Overweight	Overweight	2026-01-05